AstraZeneca COVID-19 vaccine induces robust broadly cross-reactive antibody responses in Malawian adults previously infected with SARS-CoV-2.

Chibwana MG, Moyo-Gwete T, Kwatra G, Mandolo J, Hermanaus T, Motlou T, Mzindle N, Ayres F, Chaponda M, Tembo G, Mwenechanya P, Mitole N, Jassi C, Kamng’ona R, Afran L, Mzinza D, Mwandumba HC, Gordon SB, Jere K, Madhi S, Moore PL, Heyderman RS, Jambo KC,